Y-mAbs Therapeutics
YMAB
$15.50
Share price
5.37%
Change (1 day)
151.22%
Change (1 year)
Categories
P/S ratio for Y-mAbs Therapeutics (YMAB)
P/S ratio as of April 2024 (TTM): 8.00
According to Y-mAbs Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.99992. At the end of 2023 the company had a P/S ratio of 3.51.
P/S ratio history for Y-mAbs Therapeutics from 2018 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 3.51 | 7.42% |
| 2022 | 3.27 | -83.89% |
| 2021 | 20.3 | -79.03% |
| 2020 | 96.7 | |
| 2019 | N/A | |
| 2018 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |